Cargando…
The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum
The strategy of using estrogen suppression to treat breast cancer led to the development of aromatase inhibitors, including the third-generation nonsteroidal compounds anastrozole and letrozole, and the steroidal compound exemestane. Aromatase inhibitors potently inhibit aromatase activity and also...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042921/ https://www.ncbi.nlm.nih.gov/pubmed/20616198 http://dx.doi.org/10.1093/annonc/mdq337 |